The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7–10
Open accessAbstract
In the present study we characterize the properties of the potent MCT1 (monocarboxylate transporter 1) inhibitor AR-C155858. Inhibitor titrations of L-lactate transport by MCT1 in rat erythrocytes were used to determine the Ki value and number of AR-C155858-binding sites (Et) on MCT1 and the turnover number of the transporter (kcat). Derived values were 2.3±1.4 nM, 1.29±0.09 nmol per ml of packed cells and 12.2±1.1 s−1 respectively. When expressed in Xenopus laevis oocytes, MCT1 and MCT2 were potently inhibited by AR-C155858, whereas MCT4 was not. Inhibition of MCT1 was shown to be time-dependent, and the compound was also active when microinjected, suggesting that AR-C155858 probably enters the cell before binding to an intracellular site on MCT1. Measurement of the inhibitor sensitivity of several chimaeric transporters combining different domains of MCT1 and MCT4 revealed that the binding site for AR-C155858 is contained within the C-terminal half of MCT1, and involves TM (transmembrane) domains 7–10. This is consistent with previous data identifying Phe360 (in TM10) and Asp302 plus Arg306 (TM8) as key residues in substrate binding and translocation by MCT1. Measurement of the Km values of the chimaeras for L-lactate and pyruvate demonstrate that both the C- and N-terminal halves of the molecule influence transport kinetics consistent with our proposed molecular model of MCT1 and its translocation mechanism that requires Lys38 in TM1 in addition to Asp302 and Arg306 in TM8 [Wilson, Meredith, Bunnun, Sessions and Halestrap (2009) J. Biol. Chem. 284, 20011–20021].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N., De Saedeleer, C. J., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,624
The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation
Halestrap, A. P., & Price, N. T. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3430281 · Cited by 1,348
Self-citationHalestrap, A. P., & Meredith, D. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1067-2 · Cited by 1,058
Self-citationUllah, M. S., Davies, A. J., & Halestrap, A. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511397200 · Cited by 890
Self-citationMonocarboxylate transporters in the central nervous system: distribution, regulation and function
Pierre, K., & Pellerin, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03168.x · Cited by 744
Transport of lactate and other monocarboxylates across mammalian plasma membranes
Poole, R. C., & Halestrap, A. P. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.4.c761 · Cited by 742
Self-citationIdentification of monocarboxylate transporter 8 as a specific thyroid hormone transporter
Friesema, E. C. H., Ganguly, S., Abdalla, A., Fox, J. E. M., Halestrap, A. P., & Visser, T. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300909200 · Cited by 725
Self-citationKirk, P., Wilson, M. C., Heddle, C., Brown, M. H., Barclay, A. N., & Halestrap, A. P. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.3896 · Cited by 700
Self-citationGarcia, C. K., Goldstein, J. L., Pathak, R. K., Anderson, R. G. W., & Brown, M. S. (1994) · Cell · doi:10.1016/0092-8674(94)90361-1 · Cited by 587
DIMMER, K.-S., Friedrich, B., Lang, F. J. W., Deitmer, J. W., & Bröer, S. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3500219 · Cited by 577
Cited by
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
The Science and Translation of Lactate Shuttle Theory
Brooks, G. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.008 · Cited by 1,486
“Recently, AstraZeneca developed a specific MCT1 and MCT2 inhibitor, AR-C155858 (Ovens et al., 2010), inhibiting MCT1 and MCT2 expression in Ras-transformed fibroblasts.”
BackgroundTargeting lactate metabolism for cancer therapeutics
Doherty, J. R., & Cleveland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69741 · Cited by 1,166
Haas, R., Smith, J., Rocher-Ros, V., Nadkarni, S., Montero-Melendez, T., D’Acquisto, F., Bland, E. J., Bombardieri, M., Pitzalis, C., Perretti, M., et al. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002202 · Cited by 774
The SLC16 gene family – Structure, role and regulation in health and disease
Halestrap, A. P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.05.003 · Cited by 763
Self-citationMonocarboxylate transporters in cancer
Payen, V. L., Mina, E., Van Hée, V. F., Porporato, P. E., & Sonveaux, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.07.006 · Cited by 644
San-Millán, I., & Brooks, G. A. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw127 · Cited by 610
Liu, L., MacKenzie, K. R., Putluri, N., Maletić-Savatić, M., & Bellen, H. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.024 · Cited by 556
El Hayek, L., Khalifeh, M., Zibara, V., Abi Assaad, R., Emmanuel, N., Karnib, N., El-Ghandour, R., Nasrallah, P., Bilen, M., Ibrahim, P., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1661-18.2019 · Cited by 539
Romero-Garcia, S., Moreno-Altamirano, M. M. B., Prado-Garcia, H., & Sánchez-García, F. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00052 · Cited by 506
Neuronal Stimulation Triggers Neuronal Glycolysis and Not Lactate Uptake
Díaz-García, C. M., Mongeon, R., Lahmann, C., Koveal, D., Zucker, H., & Yellen, G. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.021 · Cited by 466
“Next we applied the MCT inhibitor AR-C155858 (2 mM), and observed a small decline in the resting NADHCYT (as discussed below, this is consistent with some astrocyte-toneuron lactate shuttling at rest, as previously suspected; Mongeon et al., 2016).”
InfluentialLe Floch, R., Chiche, J., Marchiq, I., Naiken, T., Ilc, K., Murray, C. M., Critchlow, S. E., Roux, D., Simon, M.-P., & Pouysségur, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106123108 · Cited by 429
Self-citationRole of Monocarboxylate Transporters in Drug Delivery to the Brain
Vijay, N., & Morris, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990462 · Cited by 408
Whitaker-Menezes, D., Martinez-Outschoorn, U. E., Lin, Z., Ertel, A., Flomenberg, N., Witkiewicz, A. K., Birbe, R., Howell, A., Pavlides, S., Gandara, R., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15659 · Cited by 409
Monocarboxylate transporters in the brain and in cancer
Pérez-Escuredo, J., Van Hée, V. F., Sboarina, M., Falces, J., Payen, V. L., Pellerin, L., & Sonveaux, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.013 · Cited by 402
Benjamin, D., Robay, D., Hindupur, S. K., Pohlmann, J., Colombi, M., El-Shemerly, M. Y., Maira, S.-M., Moroni, C., Lane, H. A., & Hall, M. N. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.043 · Cited by 401
Role of monocarboxylate transporters in human cancers: state of the art
Pinheiro, C., Longatto-Filho, A., Azevedo-Silva, J., Casal, M., Schmitt, F. C., & Baltazar, F. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9428-1 · Cited by 368
San Martín, A., Ceballo, S., Ruminot, I., Lerchundi, R., Frommer, W. B., & Barros, L. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057712 · Cited by 361
Protein lactylation induced by neural excitation
Hagihara, H., Shoji, H., Otabi, H., Toyoda, A., Katoh, K., Namihira, M., & Miyakawa, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109820 · Cited by 349
Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates
Wang, N., Jiang, X., Zhang, S., Zhu, A., Yuan, Y., Xu, H., Lei, J., & Yan, C. (2021) · Cell · doi:10.1016/j.cell.2020.11.043 · Cited by 340
Halestrap, A. P. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c130008 · Cited by 339
Self-citationLe Douce, J., Maugard, M., Veran, J., Matos, M., Jégo, P., Vigneron, P.-A., Faivre, E., Toussay, X., Vandenberghe, M., Balbastre, Y., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.004 · Cited by 328
Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters
Marchiq, I., & Pouysségur, J. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1307-x · Cited by 300
“Recently, AstraZeneca developed a new class of a highly specific and potent MCT1/MCT2 inhibitor (Ki values in the nmol/L range), named AR-C155858 [174] capable to increase intracellular pool of lactate [128].”
BackgroundLactate: A key regulator of the immune response
Llibre, A., Kucuk, S., Gope, A., Certo, M., & Mauro, C. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.008 · Cited by 283
Short‐Chain Fatty Acid Transporters: Role in Colonic Homeostasis
Sivaprakasam, S., Bhutia, Y. D., Yang, S., & Ganapathy, V. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170014 · Cited by 266
Solute carrier transporters: the metabolic gatekeepers of immune cells
Song, W., Li, D., Tao, L., Luo, Q., & Chen, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.006 · Cited by 256
Bergersen, L. H. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.206 · Cited by 252
Witkiewicz, A. K., Whitaker-Menezes, D., Dasgupta, A., Philp, N. J., Lin, Z., Gandara, R., Sneddon, S., Martinez-Outschoorn, U. E., Sotgia, F., & Lisanti, M. P. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19530 · Cited by 239
Imaging Mitochondrial Flux in Single Cells with a FRET Sensor for Pyruvate
San Martín, A., Ceballo, S., Baeza-Lehnert, F., Lerchundi, R., Valdebenito, R., Contreras-Baeza, Y., Alegría, K., & Barros, L. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085780 · Cited by 197
Lactate as a myokine and exerkine: drivers and signals of physiology and metabolism
Brooks, G. A., Osmond, A. D., Arevalo, J. A., Duong, J. J., Curl, C. C., Moreno-Santillan, D. D., & Leija, R. G. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00497.2022 · Cited by 171
Stress gates an astrocytic energy reservoir to impair synaptic plasticity
Murphy-Royal, C., Johnston, A. D., Boyce, A. K. J., Diaz-Castro, B., Institoris, A., Peringod, G., Zhang, O., Stout, R. F., Spray, D. C., Thompson, R. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15778-9 · Cited by 158
Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms
Rusu, V., Hoch, E., Mercader, J. M., Tenen, D. E., Gymrek, M., Hartigan, C. R., DeRan, M., von Grotthuss, M., Fontanillas, P., Spooner, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.011 · Cited by 152
“Cells were pre-treated with the SLC16/MCT inhibitor AR-C155858 (Ovens et al., 2010).”
BackgroundMethodMonitoring ATP dynamics in electrically active white matter tracts
Trevisiol, A., Saab, A. S., Winkler, U., Marx, G., Imamura, H., Möbius, W., Kusch, K., Nave, K.-A., & Hirrlinger, J. (2017) · eLife · doi:10.7554/elife.24241 · Cited by 151
Rossi, A., Rigotto, G., Valente, G., Giorgio, V., Basso, E., Filadi, R., & Pizzo, P. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.060 · Cited by 109
“Then, cells were treated with a specific MCT inhibitor (AR-C155858; Ovens et al., 2010), decreasing cytosolic pyruvate levels due to the ongoing mitochondrial pyruvate uptake and oxidation (San Martı́n et al.”
BackgroundGlucose and lactate as metabolic constraints on presynaptic transmission at an excitatory synapse
Lucas, S. J., Michel, C. B., Marra, V., Smalley, J. L., Hennig, M. H., Graham, B. P., & Forsythe, I. D. (2018) · The Journal of Physiology · doi:10.1113/jp275107 · Cited by 39
“…MCT2 468 inhibitor (IC50 24 µM in Xenopus oocytes, Broer et al., 1999), and 1 µM AR-C155858, 469 a non-competitive MCT1/2 inhibitor that diffuses into cells and binds to the 470 intracellular domain of the MCTs (Ki 2-10 nM in rat erythrocytes and Xenopus 471 oocytes, Ovens et al., 2010).”
BackgroundConsumption and Metabolism of Extracellular Pyruvate by Cultured Rat Brain Astrocytes
Denker, N., Harders, A. R., Arend, C., & Dringen, R. (2023) · Neurochemical Research · doi:10.1007/s11064-022-03831-6 · Cited by 22
Metadata
- Authors
- Ovens, M. J., Davies, A. J., Wilson, M. C., Murray, C. M., & Halestrap, A. P.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2010-01-15
- Volume
- 425
- Issue
- 3
- Pages
- 523-530
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2026138483
- Cited by
- 260
- References
- 45
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.